Albemarle (NYSE:ALB) Shares Gap Down After Analyst Downgrade

Albemarle Co. (NYSE:ALBGet Free Report)’s share price gapped down prior to trading on Tuesday after Citigroup lowered their price target on the stock from $85.00 to $64.00. The stock had previously closed at $57.39, but opened at $56.00. Citigroup currently has a neutral rating on the stock. Albemarle shares last traded at $55.95, with a volume of 207,804 shares changing hands.

Other equities research analysts have also recently issued research reports about the stock. UBS Group lowered their target price on shares of Albemarle from $86.00 to $64.00 and set a “neutral” rating on the stock in a report on Monday, April 7th. Royal Bank of Canada reduced their target price on Albemarle from $133.00 to $114.00 and set an “overweight” rating for the company in a report on Wednesday, February 12th. BMO Capital Markets lowered their price target on shares of Albemarle from $150.00 to $140.00 in a report on Wednesday, February 12th. Clarkson Capital initiated coverage on shares of Albemarle in a report on Tuesday, January 14th. They issued a “buy” rating and a $112.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Albemarle from $109.00 to $105.00 in a research report on Wednesday, February 12th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $96.05.

View Our Latest Research Report on Albemarle

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ALB. Assetmark Inc. increased its holdings in shares of Albemarle by 340.6% during the fourth quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 235 shares in the last quarter. Trust Co. of Vermont raised its holdings in Albemarle by 606.5% in the fourth quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company’s stock worth $28,000 after buying an additional 279 shares during the last quarter. SJS Investment Consulting Inc. bought a new position in shares of Albemarle in the first quarter worth approximately $32,000. First Community Trust NA grew its holdings in shares of Albemarle by 55.0% during the fourth quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company’s stock valued at $34,000 after buying an additional 142 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Albemarle during the fourth quarter valued at approximately $34,000. 92.87% of the stock is currently owned by institutional investors.

Albemarle Stock Performance

The business’s fifty day moving average is $72.46 and its two-hundred day moving average is $88.02. The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $6.35 billion, a PE ratio of -4.82 and a beta of 1.59.

Albemarle (NYSE:ALBGet Free Report) last released its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) EPS for the quarter, missing the consensus estimate of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. Equities research analysts predict that Albemarle Co. will post -0.04 earnings per share for the current year.

Albemarle Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Friday, March 14th were paid a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a dividend yield of 3.00%. The ex-dividend date of this dividend was Friday, March 14th. Albemarle’s dividend payout ratio is presently -14.46%.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Stories

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.